event-trade登录编辑
📰 ReutersReutersQwen · 实盘不做把握 7/10
北京时间·🕒 发布 15:45:44时区推断·⟳ 抓取 15:48:42·⚡ 决策 08-07 15:54:38 +5m56s·81.2 天前

欧股周五小幅收高、医疗板块领涨,Genmab业绩超预期并上调全年指引涨7.2%

📄 原文Reuters↗ 原文
European shares edged higher on Friday, led ‌by healthcare stocks, though rising oil prices and renewed Middle East ten…
不做 Genmab(GMAB.US)
本条为欧股市场综述而非一手催化;Genmab上半年业绩超预期+上调全年指引已在哥本哈根市场当日定价(盘中+7.2%),美股ADR开盘将向母市场价格收敛,追开盘价无剩余edge,属平价追高,不做
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-08-07 · 扩散 medium · price-in 风险 high ↗ ↗

消息传播链

  1. 2026-08-07 07:27 UTC首发Reuters一手源原文 ↗
    本地信号库已抓到Reuters原文《Global equity funds draw inflows for 11th week as upbeat earnings lift sentiment》,发布时间早于当前社媒/聚合转述,用作本次催化首发锚点。

原文全文

展开原文 · 1,458 字
European shares edged higher on Friday, led ‌by healthcare stocks, though rising oil prices and renewed Middle East tensions kept risk appetite in check.

The pan-European STOXX 600 (.STOXX) rose 0.2% to ​659.59 points by 0731 GMT, and was on ​track for a fourth consecutive weekly advance.

The return of ⁠geopolitical concerns has tempered the optimism that drove markets ​to record levels earlier this week, with investors weighing the ​inflationary impact of higher energy prices ahead of a key U.S. jobs report later in the day.

Brent futures extended gains, rising $83.29 a barrel ​on further concerns around the opening of the Strait ​of Hormuz. Iran, working with Oman, suggested banning vessels deemed hostile from ‌the ⁠strait and heavily fining those that violated the proposed rules.

Focus will now turn to U.S. payrolls data for clues on the interest-rate outlook. U.S. job growth is expected to have ​accelerated in ​July, underscoring the ⁠resilience of the labour market and giving the Federal Reserve room to remain focused on ​inflation.

Earnings also drove market moves. Insurers (.SXIP) led ​sectoral declines, ⁠falling 0.6%, after Munich Re (MUVGn.DE) slid 3.7% despite reporting a 6% rise in second-quarter net profit, beating expectations of a decline.

Healthcare ⁠stocks (.SXDP) ​led gains, rising 1.3%. Genmab (GMAB.CO) jumped ​7.2% after the cancer drugmaker reported higher first-half revenue and raised its full-year ​outlook.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。